STERIS Net Total Equity Issued/Repurchased 2010-2025 | STE
STERIS annual/quarterly net total equity issued/repurchased history and growth rate from 2010 to 2025. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
- STERIS net total equity issued/repurchased for the quarter ending March 31, 2025 was $-0.186B, a 14273.7% increase year-over-year.
- STERIS net total equity issued/repurchased for the twelve months ending March 31, 2025 was $-0.528B, a 2179.39% increase year-over-year.
- STERIS annual net total equity issued/repurchased for 2025 was $-0.186B, a 14273.7% increase from 2024.
- STERIS annual net total equity issued/repurchased for 2024 was $-0.001B, a 99.58% decline from 2023.
- STERIS annual net total equity issued/repurchased for 2023 was $-0.307B, a 571.11% increase from 2022.
| STERIS Annual Net Total Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2025 | $-186 |
| 2024 | $-1 |
| 2023 | $-307 |
| 2022 | $-46 |
| 2021 | $12 |
| 2020 | $-17 |
| 2019 | $-68 |
| 2018 | $-54 |
| 2017 | $-88 |
| 2016 | $-3 |
| 2015 | $-2 |
| 2014 | $-10 |
| 2013 | $15 |
| 2012 | $-51 |
| 2011 | $-17 |
| 2010 | $14 |
| 2009 | $-47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $23.322B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.550B | 80.39 |
| Thermo Fisher Scientific (TMO) | United States | $147.321B | 17.82 |
| Edwards Lifesciences (EW) | United States | $42.980B | 28.18 |
| IDEXX Laboratories (IDXX) | United States | $41.867B | 48.11 |
| Alcon (ALC) | Switzerland | $41.867B | 28.29 |
| DexCom (DXCM) | United States | $32.086B | 49.59 |
| IQVIA Holdings (IQV) | United States | $26.659B | 14.93 |
| Mettler-Toledo (MTD) | United States | $23.912B | 28.44 |
| Waters (WAT) | United States | $20.299B | 28.64 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.846B | 0.00 |
| Hologic (HOLX) | United States | $14.293B | 15.53 |
| Sysmex ADR (SSMXY) | Japan | $10.555B | 29.94 |
| Penumbra (PEN) | United States | $9.912B | 77.80 |
| Masimo (MASI) | United States | $8.638B | 31.86 |
| Globus Medical (GMED) | United States | $7.871B | 18.75 |
| Glaukos (GKOS) | United States | $5.703B | 0.00 |
| Teleflex (TFX) | United States | $5.194B | 8.57 |
| TransMedics (TMDX) | United States | $4.607B | 100.15 |
| Integer Holdings (ITGR) | United States | $4.154B | 21.77 |
| PROCEPT BioRobotics (PRCT) | United States | $3.266B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.418B | 14.40 |
| Veracyte (VCYT) | United States | $2.096B | 29.41 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.586B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.337B | 0.00 |
| Artivion (AORT) | United States | $1.271B | 119.08 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.944B | 5.02 |
| Beta Bionics (BBNX) | United States | $0.790B | 0.00 |
| IRadimed (IRMD) | United States | $0.737B | 37.41 |
| SiBone (SIBN) | United States | $0.731B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.549B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.510B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.506B | 11.86 |
| OrthoPediatrics (KIDS) | United States | $0.495B | 0.00 |
| AxoGen (AXGN) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.413B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| NeuroPace (NPCE) | United States | $0.354B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 8.47 |
| ClearPoint Neuro (CLPT) | United States | $0.313B | 0.00 |
| 908 Devices (MASS) | United States | $0.264B | 0.00 |
| Neuronetics (STIM) | United States | $0.230B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.152B | 0.00 |
| CVRx (CVRX) | United States | $0.148B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.47 |